OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KRAS: A Druggable Target in Colon Cancer Patients
Francesca Negri, Lorena Bottarelli, Gian Luigi de’Angelis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4120-4120
Open Access | Times Cited: 37
Francesca Negri, Lorena Bottarelli, Gian Luigi de’Angelis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4120-4120
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Prognostic and predictive molecular biomarkers in advanced colorectal cancer
Valentino Martelli, Alessandro Pastorino, Alberto Sobrero
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108239-108239
Closed Access | Times Cited: 36
Valentino Martelli, Alessandro Pastorino, Alberto Sobrero
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108239-108239
Closed Access | Times Cited: 36
Targeting KRASG12C in colorectal cancer: the beginning of a new era
Davide Ciardiello, Brigida Anna Maiorano, Erika Martinelli
ESMO Open (2022) Vol. 8, Iss. 1, pp. 100745-100745
Open Access | Times Cited: 24
Davide Ciardiello, Brigida Anna Maiorano, Erika Martinelli
ESMO Open (2022) Vol. 8, Iss. 1, pp. 100745-100745
Open Access | Times Cited: 24
KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics
Ioannis A. Voutsadakis
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103987-103987
Closed Access | Times Cited: 15
Ioannis A. Voutsadakis
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103987-103987
Closed Access | Times Cited: 15
Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma
Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154947-154947
Closed Access | Times Cited: 15
Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154947-154947
Closed Access | Times Cited: 15
HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms
Shruti Ghai, Rejina Shrestha, Kuo‐Hui Su
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Shruti Ghai, Rejina Shrestha, Kuo‐Hui Su
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Antagonistic interaction between miR-143 and KRAS gene regulating male mouse germ cell apoptosis
Lu Yu, Shudong Niu, Guisheng Zhang, et al.
Theriogenology (2025) Vol. 235, pp. 121-133
Closed Access
Lu Yu, Shudong Niu, Guisheng Zhang, et al.
Theriogenology (2025) Vol. 235, pp. 121-133
Closed Access
Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database
Razvan Constantin Vonica, Claudiu Morgovan, Anca Butucă, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 663-663
Open Access
Razvan Constantin Vonica, Claudiu Morgovan, Anca Butucă, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 663-663
Open Access
Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer
Han Wu, Jialin Zhang, Qiujie Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Han Wu, Jialin Zhang, Qiujie Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploration of the Prognostic Value of m5C Methylation Protein NOP2 and NSUN6 in Colon Cancer
Bin Jiang, Jie Li, Jianguo Wang
Genetic Testing and Molecular Biomarkers (2025)
Closed Access
Bin Jiang, Jie Li, Jianguo Wang
Genetic Testing and Molecular Biomarkers (2025)
Closed Access
In Silico Identification of Putative Allosteric Pockets and Inhibitors for the KRASG13D-SOS1 Complex in Cancer Therapy
Zehra Sarica, Özge Kürkçüoğlu, Fethiye Aylin Sungur
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3293-3293
Open Access
Zehra Sarica, Özge Kürkçüoğlu, Fethiye Aylin Sungur
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3293-3293
Open Access
MVK, induced by Kras, represses cGAS-Sting signalling in lung adenocarcinoma
Changsheng Zhou, Jia Liu, Xudong Hu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Changsheng Zhou, Jia Liu, Xudong Hu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer
Yao Peng, Zhili Zhang, Gong‐Li Yang, et al.
APOPTOSIS (2023) Vol. 29, Iss. 3-4, pp. 331-343
Closed Access | Times Cited: 10
Yao Peng, Zhili Zhang, Gong‐Li Yang, et al.
APOPTOSIS (2023) Vol. 29, Iss. 3-4, pp. 331-343
Closed Access | Times Cited: 10
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
Alberto Puccini, Andreas Seeber, Martin D. Berger
Cancers (2022) Vol. 14, Iss. 19, pp. 4828-4828
Open Access | Times Cited: 15
Alberto Puccini, Andreas Seeber, Martin D. Berger
Cancers (2022) Vol. 14, Iss. 19, pp. 4828-4828
Open Access | Times Cited: 15
OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway
Yong Tang, Yi Liu, Xiaobo Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Yong Tang, Yi Liu, Xiaobo Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study
Chunhui Rao, Jingfei Tong, Yan Yang
Medicine (2024) Vol. 103, Iss. 13, pp. e37517-e37517
Open Access | Times Cited: 2
Chunhui Rao, Jingfei Tong, Yan Yang
Medicine (2024) Vol. 103, Iss. 13, pp. e37517-e37517
Open Access | Times Cited: 2
Biological and Clinical Characteristics of Proximal Colon Cancer: Far from Its Anatomical Subsite
Qing Yang, Ruize Qu, Siyi Lu, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 10, pp. 1824-1839
Open Access | Times Cited: 2
Qing Yang, Ruize Qu, Siyi Lu, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 10, pp. 1824-1839
Open Access | Times Cited: 2
Gut microbiota influence on lung cancer risk through blood metabolite mediation: from a comprehensive Mendelian randomization analysis and genetic analysis
Yizhao Du, Qin Wang, Zongmei Zheng, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Yizhao Du, Qin Wang, Zongmei Zheng, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification
Shijie Zhang, Yan Wang, Xiaodong Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Shijie Zhang, Yan Wang, Xiaodong Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Transglutaminase 2 serves as a pathogenic hub gene of KRAS mutant colon cancer based on integrated analysis
Peng Weibin, Yuping Li, Yong Zeng, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 2074-2090
Open Access | Times Cited: 1
Peng Weibin, Yuping Li, Yong Zeng, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 2074-2090
Open Access | Times Cited: 1
Synergistic two-step inhibition approach using a combination of trametinib and onvansertib in KRAS and TP53-mutated colorectal adenocarcinoma
Daeun Kim, Hyun‐Ji Oh, Hyunjin Kim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117796-117796
Closed Access | Times Cited: 1
Daeun Kim, Hyun‐Ji Oh, Hyunjin Kim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117796-117796
Closed Access | Times Cited: 1
Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP
Yannan Xia, Shujie Zhang, Hongyi Luo, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176157-176157
Closed Access | Times Cited: 3
Yannan Xia, Shujie Zhang, Hongyi Luo, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176157-176157
Closed Access | Times Cited: 3
Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
Yuda Zhang, Fanxu Zeng, Shixuan Peng, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 9, pp. 743-751
Closed Access | Times Cited: 2
Yuda Zhang, Fanxu Zeng, Shixuan Peng, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 9, pp. 743-751
Closed Access | Times Cited: 2
Expression pattern of secretory‐cell‐related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes
Rui Zhou, Lingbo Li, Shaoyan Xi, et al.
Molecular Oncology (2022) Vol. 17, Iss. 3, pp. 499-517
Open Access | Times Cited: 3
Rui Zhou, Lingbo Li, Shaoyan Xi, et al.
Molecular Oncology (2022) Vol. 17, Iss. 3, pp. 499-517
Open Access | Times Cited: 3
Discovery, Optimization and Biological Activity Evaluation of Genipin Derivatives as Potential Kras G12d Inhibitors
Ran Sun, Yangfan Hu, Xiangwen Liu, et al.
(2024)
Closed Access
Ran Sun, Yangfan Hu, Xiangwen Liu, et al.
(2024)
Closed Access
WWP1 inhibition increases SHP2 inhibitor efficacy in colorectal cancer
Hao Fan, Xuefei Hu, Fuao Cao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Hao Fan, Xuefei Hu, Fuao Cao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
